Understanding adjuvant endocrine therapy persistence in breast Cancer survivors

Understanding adjuvant endocrine therapy persistence in breast Cancer survivors

Abstract Background Adjuvant endocrine therapy (AET) significantly decreases the risk of breast cancer recurrence and mortality. Notwithstanding the demonstrated efficacy of AET, 31–73% of breast cancer survivors do not persist with AET. The purpose of this study was to explore breast cancer survivo...

Full description

Bibliographic Details
Main Authors: Leah K. Lambert, Lynda G. Balneaves, A. Fuchsia Howard, Stephen K. Chia, Carolyn C. Gotay
Format: Article
Language:English
Published: BMC 2018-07-01
Series:BMC Cancer
Subjects:
Adjuvant endocrine therapy
Medication persistence
Breast cancer
Cancer survivorship
Online Access:http://link.springer.com/article/10.1186/s12885-018-4644-7

Internet

http://link.springer.com/article/10.1186/s12885-018-4644-7

Similar Items